Digital gastrointestinal care startup Salvo Health announced it closed a $5 million Seed Prime round led by City Light Capital and Human Ventures led the round.

数字胃肠道护理初创公司Salvo Health宣布，它结束了由City Light Capital和Human Ventures牵头的一轮价值500万美元的种子优质投资。

The company's existing investors also participated in the round, including Torch Capital, Threshold Ventures and Felicis Ventures. Angel investors Anmol Madan, founder of Ginger Health and Teladoc's former chief data scientist also contributed.

该公司的现有投资者也参与了这轮投资，包括Torch Capital、Threshold Ventures和Felicis Ventures。天使投资人安莫尔·马丹（AnmolMadan）是Ginger Health的创始人，也是Teladoc的前首席数据科学家。

Emily Melton of Threshold, Rachel Parlier of City Light, and Salvo's founder and CEO Jeffrey Glueck will join Salvo's board of directors.

Threshold的艾米丽·梅尔顿（EmilyMelton）、City Light的瑞秋·帕利尔（RachelParlier）以及Salvo的创始人兼首席执行官杰弗里·格卢克（JeffreyGlueck）将加入Salvo的董事会。

WHAT IT DOES

它的功能

The New York-based company offers a virtual clinic geared toward people with chronic gastrointestinal and metabolic liver issues, including celiac disease, fatty liver disease,  irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), small intestinal bacterial overgrowth (SIBO) and dyspepsia.

这家总部位于纽约的公司为患有慢性胃肠道和代谢性肝病的患者提供虚拟诊所，包括乳糜泻、脂肪肝、肠易激综合征（IBS）、胃食管反流病（GERD）、小肠细菌过度生长（SIBO）和消化不良。

The company says it offers 'wraparound care' in a hybrid approach, allowing patients to continue under their local physician and access Salvo's app-based support.

该公司表示，它以混合方式提供“全面护理”，允许患者继续接受当地医生的治疗，并获得Salvo基于应用程序的支持。

Through Salvo, users are matched with a care team made up of registered dietitians, behavioral health specialists and licensed nurses, and can receive insurance-covered interdisciplinary care.

通过Salvo，用户可以与由注册营养师、行为健康专家和持照护士组成的护理团队相匹配，并可以获得保险覆盖的跨学科护理。

The company will use the funds to scale its wraparound GI services to providers, including accountable care organizations, gastroenterology private practices and health systems.

该公司将利用这些资金将其全面的胃肠道服务扩展到提供者，包括负责任的护理组织、肠胃科私人诊所和卫生系统。

'I am delighted to lead this investment in Salvo Health and their innovative wraparound care for GI and metabolic chronic conditions,' Parlier of City Light Capital said in a statement. 'As an early-stage impact investor, we look for companies with the potential to not just transform industries, but also to improve lives.

City Light Capital的帕利尔（Parlier）在一份声明中说，我很高兴领导这项对Salvo Health的投资，以及他们对胃肠道和代谢性慢性病的创新性全面护理作为早期影响力投资者，我们寻找的公司不仅有潜力改造行业，而且有潜力改善生活。

Salvo is enabling GI practices and health systems to fill in the gaps for underserved patient populations, especially for high-touch follow-on care between appointments and post-procedures.' 

Salvo使GI实践和卫生系统能够填补服务不足患者群体的空白，特别是在预约和手术后的高接触后续护理方面。”

Salvo launched in 2022 with $10.5 million in funding to scale its virtual clinic for chronic GI conditions.

Salvo于2022年以1050万美元的资金启动，以扩大其慢性胃肠道疾病虚拟诊所的规模。

Other companies in the virtual digestive care space include Vivante Health, which secured $31 million in funding in September, and Oshi Health, which garnered $30 million in Series B funding in April.

虚拟消化护理领域的其他公司包括Vivante Health，该公司于9月获得3100万美元的资金，以及Oshi Health，该公司于4月获得3000万美元的B系列资金。

'Streamlining AI-Enabled Digital Health Technologies From Research to Implementation' is scheduled for Tuesday, March 12, 1:30-2:30 p.m. ET, in W304A at HIMSS24 in Orlando. 

“将人工智能支持的数字健康技术从研究简化为实施”计划于美国东部时间3月12日星期二下午1:30-2:30在W304A奥兰多HIMSS24举行。